The default category

New insight into AMD progression presented at CRATER

At the CRATER Conference in Warsaw, Poland, Prof. Michel Paques gave an update on clinical research on AMD, conducted by…

New solutions for AO imaging presented at ARVO

During ARVO 2023 in New Orleans, we were thrilled to present and discuss in person our solutions for cellular-resolution…

ARVO 2023 – rtx1 users present new clinical findings

This year, users of the rtx1 AO cameras will introduce new biomarkers and methods for AO studies, as well as novel clinical…

Many thanks to customers who presented at ISER 2023

Last week at the ISER 2023 biennal meeting, users of Imagine Eyes' retinal imaging devices have shared their work and findings…

Great presentations at the AO-Vision symposium !

Last week, rtx1 users presented their work in IRDs at the AO-vision symposium.

Imagine Eyes appoints Maelys Bellay as QA/RA specialist

Maelys Bellay recently joined our Quality Assurance and Regulatory Affairs (QA/RA) team at Imagine Eyes. “I am happy to…

Imagine Eyes selected for Bpifrance accelerator program

We are happy to share that Imagine Eyes is laureate for a second accelerator program in less than one year! This month,…

Imagine Eyes to meet pharmas to speed up the development of therapies

To accelerate the clinical development of new retinal treatments, we propose to implement advanced retinal imaging technology…

Deciphering AMD: cellular phenotyping & short term progression

Interview & discussion with 3 ophthalmology professors about the use of AO retinal imaging in dry AMD.

Imagine Eyes laureate of NEXT French Healthcare

We are happy to share that Imagine Eyes has been selected for NEXT French Healthcare, an acceleration program dedicated…